Glaxo in bid for Pfizer's Listerine business
GlaxoSmithKline was today at the centre of speculation linking it to an €11.6bn bid for Pfizer’s Listerine-to-Sudafed consumer healthcare arm.
Such a move would transform Glaxo into the world’s biggest maker of non-prescription drugs, as well as the second largest prescription drugs supplier.





